Correction to A Novel Covalent mTOR Inhibitor, DHM25, Shows in Vivo Antitumor Activity against Triple-Negative Breast Cancer Cells. | J Med Chem;62(20): 9339-9340, 2019 Oct 24. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Correction to A Novel Covalent mTOR Inhibitor, DHM25, Shows in Vivo Antitumor Activity against Triple-Negative Breast Cancer Cells.

Fouqué, Amélie; Delalande, Olivier; Jean, Mickael; Castellano, Rémy; Josselin, Emmanuelle; Malleter, Marine; Shoji, Kenji F; Hung, Mac Dinh; Rampanarivo, Hariniaina; Collette, Yves; van de Weghe, Pierre; Legembre, Patrick.

J Med Chem ; 62(20): 9339-9340, 2019 Oct 24.

Article in En | MEDLINE | ID: mdl-31603322

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2019 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2019 Document type: Article